WIRE – Novel Treatments in Renal Cell Cancer
Condition(s):Renal Cell CancerLast Updated:June 7, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Renal Cell CancerLast Updated:June 7, 2023Recruiting
Condition(s):Metastatic Renal Cell CancerLast Updated:January 10, 2019Completed
Condition(s):Renal Cell CancerLast Updated:February 18, 2022Completed
Condition(s):Renal Cell Carcinoma (RCC)Last Updated:December 22, 2020Completed
Condition(s):Hepatitis C; Renal Cell Carcinoma; Colorectal CancerLast Updated:September 17, 2014Completed
Condition(s):Kidney CancerLast Updated:July 13, 2020Completed
Condition(s):Kidney Cancer; Renal Cell CarcinomaLast Updated:December 31, 2020Completed
Condition(s):Metastatic Renal Cell Carcinoma; Metastatic Clear-cell Renal Cancer; Recurrent Renal Cell Carcinoma; Refractory Renal Cell Carcinoma; Metastatic Kidney CancerLast Updated:April 6, 2022Completed
Condition(s):Renal Cell Carcinoma; Renal Cell Carcinoma MetastaticLast Updated:November 29, 2022Recruiting
Condition(s):Renal Cell Cancer; Metastatic Renal Cell CancerLast Updated:May 3, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.